Age-related Changes in Sleep-wake Regulation
- Conditions
- Sleep Deprivation
- Interventions
- Behavioral: Prolonged wakefulness
- Registration Number
- NCT03813082
- Lead Sponsor
- University of Zurich
- Brief Summary
A sleep deprivation protocol combined with state-of-the-art, simultaneous positron emission tomography and magnetic resonance spectroscopy imaging will be employed to investigate the effects of sleep deprivation and aging on hypothesized molecular markers of sleep need.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 29
- healthy male individuals
- age: 20-35 or 60-70 years
- right-handed
- non-smokers
- moderate caffeine/alcohol consumption
- normal BMI
- Sleep/circadian rhythms disturbances
- former brain injuries with loss of consciousness and brain anomalies
- drug intake/consumption
- medication intake
- cardiac pacemaker
- neurological disorders
- prior participation (during past 2 years) in radiological or nuclear experiment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Sleep deprivation young men Prolonged wakefulness Young study participants will complete four nights in the sleep laboratory, whereas they will stay awake during one night. PET brain imaging will be conducted at the same circadian time on three consecutive afternoons (prior, during and after prolonged wakefulness). Additionally, validated tests of vigilance and cognitive performance will be administered and the brain waves will be recorded in wakefulness and sleep. Sleep deprivation older men Prolonged wakefulness Older study participants will complete four nights in the sleep laboratory, whereas they will stay awake during one night. PET brain imaging will be conducted at the same circadian time on three consecutive afternoons (prior, during and after prolonged wakefulness). Additionally, validated tests of vigilance and cognitive performance will be administered and the brain waves will be recorded in wakefulness and sleep.
- Primary Outcome Measures
Name Time Method Sleep-wake induced change in cerebral availability of mGluR5 (metabotropic glutamate receptors of subtype 5) Change from baseline metabotropic glutamate receptors of subtype 5 availability after 33 hours of prolonged wakefulness and 8 hours of recovery sleep Positron emission tomography
- Secondary Outcome Measures
Name Time Method Sleep-wake induced change in waking electroencephalogram (EEG) Change from baseline waking EEG during 33 hours of prolonged wakefulness and after 8 hours of recovery sleep Spectral composition of the EEG in wakefulness
Sleep-wake induced change in subjective state Change from baseline sleepiness during 33 hours of prolonged wakefulness and after 8 hours of recovery sleep Subjective sleepiness as quantified with the Stanford Sleepiness Scale (range: 1 to 7)
Sleep-wake induced change in cognitive performance Change from baseline cognitive performance during 33 hours of prolonged wakefulness and after 8 hours of recovery sleep Cognitive performance battery including tasks measuring sustained attention, executive functioning and working memory
Sleep-wake induced change in potential molecular markers of sleep need Change from baseline microRNA, fragile X mental retardation protein and brain-derived neurotrophic factor concentrations after 33 hours of prolonged wakefulness and 8 hours of recovery sleep microRNAs, fragile X mental retardation protein, and brain-derived neurotrophic factor concentrations in peripheral blood
Sleep-wake induced change in glutamate concentration in prefrontal cortex and basal ganglia Change from baseline glutamate concentration after 33 hours of prolonged wakefulness and 8 hours of recovery sleep Magnetic resonance spectroscopy
Sleep-wake induced change in sleep electroencephalogram (EEG) Change from all-night baseline sleep EEG in 8 hours of recovery sleep after 33 hours of prolonged wakefulness Spectral composition of the EEG during sleep